InvestorsHub Logo

Know-Fear

09/28/21 10:00 AM

#404877 RE: Basin Street Blues #404876

Point taken. I didn’t think cash was an issue for MRK, however declining Keytruda sales likely a concern at some levels.

(Key series for a Canadian baseball team against a team from south of the Border….that many have no affinity for)

beachhyena

09/28/21 10:19 AM

#404884 RE: Basin Street Blues #404876

Can you confirm that Merck has actually closed this deal as it looks like they are not the only potential suitors of Acceleron. BMY has the most ties with Acceleron. I cannot find confirmation.

sukus

09/28/21 10:45 AM

#404895 RE: Basin Street Blues #404876

They can issue stock if they wanted to buy the company. In addition, I believe stock transaction is better than cash transaction in the midst of 40% cap gain tax. Who want to get hair cut with that tax?